{
    "organizations": [],
    "uuid": "e65a63722ecfa3c02e8eb92e9bd51594385fcd97",
    "author": "cnbc.com",
    "url": "https://www.cnbc.com/2018/02/08/the-associated-press-innoviva-beats-street-4q-forecasts.html",
    "ord_in_thread": 0,
    "title": "Innoviva beats Street 4Q forecasts",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "BRISBANE, Calif. (AP) _ Innoviva Inc. (INVA) on Thursday reported fourth-quarter earnings of $58.4 million.\nThe Brisbane, California-based company said it had profit of 45 cents per share.\nThe results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 45 cents per share.\nThe biopharmaceutical company posted revenue of $69.5 million in the period, also exceeding Street forecasts. Three analysts surveyed by Zacks expected $65.2 million.\nFor the year, the company reported profit of $134.1 million, or $1.17 per share. Revenue was reported as $217.2 million.\nInnoviva shares have dropped almost 3 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $13.80, a rise of 26 percent in the last 12 months.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on INVA at https://www.zacks.com/ap/INVA",
    "published": "2018-02-09T02:06:00.000+02:00",
    "crawled": "2018-02-09T02:35:58.014+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "brisbane",
        "ap",
        "innoviva",
        "inva",
        "thursday",
        "reported",
        "earnings",
        "million",
        "brisbane",
        "company",
        "said",
        "profit",
        "cent",
        "per",
        "share",
        "result",
        "beat",
        "wall",
        "street",
        "expectation",
        "average",
        "estimate",
        "four",
        "analyst",
        "surveyed",
        "zacks",
        "investment",
        "research",
        "earnings",
        "cent",
        "per",
        "share",
        "biopharmaceutical",
        "company",
        "posted",
        "revenue",
        "million",
        "period",
        "also",
        "exceeding",
        "street",
        "forecast",
        "three",
        "analyst",
        "surveyed",
        "zacks",
        "expected",
        "million",
        "year",
        "company",
        "reported",
        "profit",
        "million",
        "per",
        "share",
        "revenue",
        "reported",
        "million",
        "innoviva",
        "share",
        "dropped",
        "almost",
        "percent",
        "since",
        "beginning",
        "year",
        "final",
        "minute",
        "trading",
        "thursday",
        "share",
        "hit",
        "rise",
        "percent",
        "last",
        "month",
        "story",
        "generated",
        "automated",
        "insight",
        "http",
        "using",
        "data",
        "zacks",
        "investment",
        "research",
        "access",
        "zacks",
        "stock",
        "report",
        "inva",
        "http"
    ]
}